Skip to content

GFR PHARMACEUTICALS INC: 10-Q filed 2011-08-12

What GFR PHARMACEUTICALS INC reported in its quarterly report filed 2011-08-12 (fiscal Q2 2011): 33 published measures, 88 facts as tagged in accession 0001437749-11-005893.

This filing

Form
10-Q (quarterly report)
Filed
2011-08-12
Fiscal period
fiscal Q2 2011
Accession
0001437749-11-005893 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GFR PHARMACEUTICALS INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-06-309,960,788USD
At 2010-12-318,822,320USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-06-301,808,144USD
At 2010-12-311,861,052USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-06-307,505,628USD
At 2010-12-316,358,268USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-06-30383,755USD
At 2010-12-31300,716USD
At 2010-06-30398,954USD
At 2009-12-3155,486USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30725,534USD91
2011-01-01 to 2011-06-301,043,662USD181
2010-04-01 to 2010-06-30862,541USD91
2010-01-01 to 2010-06-301,127,952USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-06-30272,014USD181
2010-01-01 to 2010-06-30576,258USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-06-30200,598USD181
2010-01-01 to 2010-06-30277,992USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-06-303,907USD181
2010-01-01 to 2010-06-3040,505USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-200,598USD181
2010-01-01 to 2010-06-30-277,992USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-06-302,533,727USD
At 2010-12-311,490,065USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2011-04-01 to 2011-06-3042,079,940shares91
2011-01-01 to 2011-06-3042,079,940shares181
2010-04-01 to 2010-06-3042,079,940shares91
2010-01-01 to 2010-06-3042,079,940shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2011-04-01 to 2011-06-30195,137USD91
2011-01-01 to 2011-06-30286,748USD181
2010-04-01 to 2010-06-30197,222USD91
2010-01-01 to 2010-06-30330,387USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-06-306,912,176USD
At 2010-12-316,957,273USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-06-30953,002USD91
2011-01-01 to 2011-06-301,373,708USD181
2010-04-01 to 2010-06-30844,493USD91
2010-01-01 to 2010-06-301,263,035USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-06-301,361,268USD
At 2010-12-311,724,119USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-06-30980,754USD
At 2010-12-311,049,497USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-06-3043,336USD
At 2010-12-3127,903USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-06-30504,187USD
At 2010-12-311,245,616USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-04-01 to 2011-06-3077,974USD91
2011-01-01 to 2011-06-30375,506USD181
2010-04-01 to 2010-06-30140,786USD91
2010-01-01 to 2010-06-30362,342USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-06-3028,782USD
At 2010-12-3135,062USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-04-01 to 2011-06-301,030,976USD91
2011-01-01 to 2011-06-301,749,214USD181
2010-04-01 to 2010-06-30985,279USD91
2010-01-01 to 2010-06-301,625,377USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2011-04-01 to 2011-06-30191,857USD91
2011-01-01 to 2011-06-30406,641USD181
2010-04-01 to 2010-06-30200,950USD91
2010-01-01 to 2010-06-30350,888USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-06-3042,079,940shares
At 2010-12-3142,079,940shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2011-06-30417,392USD
At 2010-12-31313,694USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2011-06-308,152,644USD
At 2010-12-316,961,268USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-06-30436,873USD
At 2010-12-31135,226USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-04-01 to 2011-06-30758,362USD91
2011-01-01 to 2011-06-301,087,678USD181
2010-04-01 to 2010-06-30893,119USD91
2010-01-01 to 2010-06-301,178,505USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-3055,629USD91
2011-01-01 to 2011-06-30387,658USD181
2010-04-01 to 2010-06-3094,710USD91
2010-01-01 to 2010-06-30266,162USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2011-01-01 to 2011-06-30405,937USD181
2010-01-01 to 2010-06-30371,037USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-04-01 to 2011-06-30497USD91
2011-01-01 to 2011-06-30718USD181
2010-04-01 to 2010-06-30245,848USD91
2010-01-01 to 2010-06-30245,857USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-650,011USD181
2010-01-01 to 2010-06-30-759,686USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-3015,364USD181
2010-01-01 to 2010-06-308,950USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-3014,605USD181
2010-01-01 to 2010-06-30-15,755USD181

Inspect the source

Entity
GFR PHARMACEUTICALS INC / CIK 0001096294
Captured
SEC response SHA-256
86308bf73caa2caf65af546f6e008bd3598c2150b1774d4e52782ca5e859abcc

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001096294.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))